Andrew Peter Zappia

Andrew P. Zappia is a Partner and the Practice Group Leader of the Health Care and Life Sciences IP Group at Troutman Pepper Locke LLP. He focuses his patent dispute practice on inter partes review (IPR) proceedings before the PTAB, district court litigations, and arbitrations relating to pharmaceuticals, biotechnology, and medical devices. He is experienced in the full array of issues that arise in connection with intellectual property disputes, including patent, trademark, and copyright protection and infringement; International Trade Commission proceedings; and antitrust issues. He focuses his transactional practice on national and international M&A and licensing deals in the biotech industry. Additionally, Andrew has an active abbreviated new drug application (ANDA) patent litigation practice. He has served as lead counsel in more than two dozen ANDA litigations in the U.S. and has coordinated international patent enforcement strategies in Europe, Canada, India, Japan, New Zealand, and Australia. Many of these matters have involved billion-dollar drug products. Andrew also hosts a podcast on post-issuance practice before the USPTO. Andrew is originally from New York and obtained his undergraduate degree from Tufts University and his law degree from the University of Virginia. He has been recognized in the Best Lawyers in America, Legal 500, and Super Lawyer rankings. In his spare time, he is working on obtaining his Italian citizenship and travels there frequently.